Biodesix to participate at cowen's 43rd annual healthcare conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that scott hutton, chief executive officer of biodesix, will participate in a fireside chat and host in-person 1x1 investor meetings at cowen's 43rd annual healthcare conference being held from march 6-8, 2023.
BDSX Ratings Summary
BDSX Quant Ranking